Company: BDRX
Filing Date: 2025-05-01
Form Type: DRS
Source: 0001214659-25-006756
Chunk: 145

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-01
Form: DRS
Chunk 145
---
 part of the prospectus or the registration statement of which this prospectus forms a part, has not
been approved and/or endorsed by us or the underwriter in its capacity as an underwriter and should not be relied upon by investors.

| 78 |

Price Stabilization, Short Positions

In connection with
this offering, the underwriter may engage in activities that stabilize, maintain or otherwise affect the price of our Depositary Shares
during and after this offering, including:

| ● | stabilizing transactions; |

| ● | short sales; |

| ● | purchases to cover positions created by short sales; |

| ● | imposition of penalty bids; and |

| ● | syndicate covering transactions. |

Stabilizing transactions
consist of bids or purchases made for the purpose of preventing or retarding a decline in the market price of our securities while this
offering is in progress. Stabilization transactions permit bids to purchase the underlying security so long as the stabilizing bids do
not exceed a specified maximum. These transactions may also include making short sales of our Depositary Shares, which involve the sale
by the underwriter of a greater number of Depositary Shares than they are required to purchase in this offering and purchasing Depositary
Shares on the open market to cover short positions created by short sales. Short sales may be “covered short sales,” which
are short positions in an amount not greater than the underwriters’ option to purchase additional shares referred to above, or may
be “naked short sales,” which are short positions in excess of that amount.

The underwriter
may close out any covered short position by either exercising its option, in whole or in part, or by purchasing shares in the open market.
In making this determination, the underwriter will consider, among other things, the price of shares available for purchase in the open
market as compared to the price at which they may purchase shares through the over-allotment option.

Naked short sales
are short sales made in excess of the over-allotment option. The underwriter must close out any naked short position by purchasing shares
in the open market. A naked short position is more likely to be created if the underwriter is concerned that there may be downward pressure
on the price of our Depositary Shares in the open market that could adversely affect investors who purchased in this offering.

The underwriter
also may impose a penalty bid. This occurs when a particular underwriter repays to the underwriter a portion of the underwriting